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ABSTRACT  
OBJECTIVE: The objective of the selective EBM review is to determine whether or not “Is 
Curcuma effective for the management of osteoarthritis knee pain?”  
  
STUDY DESIGN: Systematic review of three randomized controlled trials (RCT) published in 
2009, 2014, and 2016.   
 
DATA SOURCES: Three RCTs studies were found using PubMed. All articles were published 
in reviewed journals and selected based on correlation to topic choice, date of publication, and 
evaluation of POEMs.  
  
OUTCOMES MEASURED: The Western Ontario and McMaster Universities Arthritis Index 
(WOMAC) is a questionnaire that evaluates hip and knee osteoarthritis. The questions are 
divided into 3 subscales: pain, stiffness, and physical function. This paper is focusing on the pain 
scale when walking.  
 
RESULTS: Kuptniratsaikul et al. (2014) found a decrease in knee pain on the pain scale with 
Curcuma domestica with a statistically significant p-value of 0.018, showing it is as effective as 
ibuprofen in pain reduction. Srivastava et al (2016) also shows a reduction in pain when using 
Curcuma longa (CL) with diclofenac comparing to a placebo with Diclofenac group. With a 
significant p-value of 0.0001, showing CL extract along with Diclofenac produces an overall 
significant improvement in patients with knee OA. Kuptniratsaikul et al (2009) shows a 
reduction in pain in both the Curcuma domestica group and ibuprofen group, but the differences 
of the outcomes were not statistically significant with the p-value of 0.2. It cannot be definitively 
concluded if Curcuma domestica is as effective as ibuprofen.  
  
CONCLUSION: Two of the three studies shows statistical significance that Curcuma can reduce 
pain in knee osteoarthritis. While one showed no statistical significance with knee OA pain 
reduction, it is shown to be safe for the treatment of knee OA. Curcuma looks to be promising as 
a long-term treatment, but further research needs to be done.  
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INTRODUCTION 
Osteoarthritis, abbreviated as OA, is the most common form of arthritis. OA is primarily 
a disease of aging and with the increase of obesity the prevalence of OA is on the rise. It is 
caused by degeneration of cartilage that protects the joints. The degeneration of cartilage starts in 
a nonuniform manner and located focally, causing pain, swelling, and difficulty moving the 
joints effected.1,2 Even though it can affect any joint, the most common joints affected are in the 
hands, primarily the distal and proximal interphalangeal joints, as well as the knees, hips, and 
spine.2 Symptomatically, OA of the knee is the most common joint affected, occurring in about 
12% of people 60 years and older and 6% of adults 30 years and older in the United States.2  
The CDC estimates over 30 million US adults have OA.1 It is especially common in the 
geriatric population. There is no recent yearly healthcare visit for OA recorded, but in 2006 
through 2007 there were 12.3 million office visits and 85,000 hospital visits associated with 
OA.3 Since there are many options for the treatment of OA depending on the severity as well as 
many treatment options that can be bought over the counter for mild OA, it is difficult to 
calculate the total healthcare costs for OA, however, a 2013 study found the total hospitalization 
cost of OA was $16.5 billion.4 
The etiology of osteoarthritis is still not well understood. However, what is known is that 
it is categorized as a gradual loss of articular cartilage and that there are many risk factors 
involved. The most common risk factor is age. A study published in 1995 showed an increase 
incidence of osteoarthritis with age.4 Typically, the incidence increased after the age of 50 then 
leveled off or declined in both sexes after the age of 80.5 Trauma and overuse of the joint as well 
as being overweight increases the risk of OA. Genetics has shown to play a role in OA as well. 
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Studies have shown there is an increase of OA occurrence in monozygotic twins.6 Other genetic 
traits that have shown to increase OA are a defect in producing collagen, a defect in bones fitting 
together, and a genetic defect called FAAH that increases pain sensitivity causing a higher risk of 
developing OA.7 Other risk factors for OA are low bone density, low diet of vitamins C and D, 
and ethnicity. OA is more prominent in Europeans than Asians and Africans.2,7 
 Even though there is an understanding of the different risk factors for osteoarthritis, it is 
unknown why OA can vary from person to person and why there is a faster progression in some. 
Treatments are not considered curative, often resulting in joint replacement if it hinders the 
patient’s activities in daily living.7 There is still much more that needs to be learned about this 
common disease.   
The methods to treat OA depend on the severity and pain of the joint affected. Usually 
assisting devices are used along with exercise and weight loss, if applicable. Acetaminophen or 
NSAIDs are used to control pain. If a patient has moderate to severe OA of the knee and oral 
NSAIDs are ineffective, intra-articular injections of corticosteriods, hyaluronate, or platelet-rich 
plasma can be administered to relieve pain temporally. If the knee or hip affected with OA 
severely restricts the patient from walking and causes them pain at rest, then total joint 
replacment is used to improve their mobility and pain.2,8      
 Osteoarthritis can cause chronic use of NSAIDs which can lead to multiple health risks. 
Chronic use of NSAIDs can lead to increased risk of peptic ulcer diease, acute renal failure, 
decreased glomerular filtration rate, stroke, or a myocardial infarction. Since OA usually targets 
the older population, the long-term use of NSAIDS can exacerbate heart failure and 
hypertension.9 Curcuma, also known as turmeric, is a possible treatment method for OA pain. 
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Curcuma contains anti-inflammatory properties that could possibility replace NSAID use. 
Curcumin is shown to be well tolerated with few side effects. The most common side effects are 
usually gastrointestinal, such as constipation, diarrhea, and nausea.10 This paper evaluates three 
randomized controlled trials comparing the efficacy of Curcuma extract as an oral medication for 
improving osteoarthritis knee pain. 
OBJECTIVE 
The objective of the selected evidence-based medicine (EBM) review is to determine 
whether or not, “Is Curcuma longa effective for the management of osteoarthritis knee pain?” 
METHODS 
 The criteria used for the selection of the studies were based on the population, 
interventions, comparisons, outcomes measures and types of studies. The population included 
both female and male adult patients with knee OA. The studies compared Curcuma extract to 
either ibuprofen or a placebo to determine a difference in the pain while walking. The pain was 
measured by Western Ontario and McMaster Universities Osteoarthritis index (WOMAC). Three 
randomized controlled trials were selected and evaluated for this paper. Two of which were 
double blinded studies and one single blind RCT where the physicians were unaware of patients 
group of treatment. Two of the studies compared Curcuma with ibuprofen and one study 
compared Curcuma with a placebo.  
In order to find the appropriate studies for this paper while searching through the data 
sources, certain criteria was placed. Key-words included were “Curcuma” and “osteoarthritis”. 
All articles were found in PubMed and are published in peer reviewed journals in English. The 
articles were selected based on their applicability to the clinical question and included patient-
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oriented outcomes (POEMS). The inclusion criteria used were clinical trials, human studies, and 
studies published in the past 10 years. Studies published greater than 10 years ago and studies on 
animals were excluded. Statistics are reported using P-values.  
Table 1. Demographics & Characteristics of Included Studies 
Study  Type  # pts Age 
(yrs) 









>50 years with 
primary knee OA, 
morning stiffness 
<30 minutes and 
crepitus on motion. 
With a pain score 
rating scale of ≥ 5 of 
10.  














500 mg 4 times 









≥50 years, primary 
knee OA with a 
numerical rating 
scale of knee pain of 
≥5 out of 10 
Patient with 
abnormal liver 
function or renal 
function, history of 
peptic ulcer, 
allergy to curcuma 
or ibuprofen, 
unable to walk  
36 Ibuprofen group 
received 1,200 















40-80 years old, 
have knee OA with 
stiffness <30 min, 
crepitus, bony 
tenderness, bony 
enlargement and no 
palpable warmth 
Patients less than 
40 or greater than 









with any systemic 
disease     
27 500mg placebo 




extract with 50 
mg/day 
Diclofenac for 4 
months  
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OUTCOMES MEASURED:    
Two studies used Western Ontario and McMaster Universities Arthritis Index (WOMAC) 
to measure the outcome for OA knee pain based on curcuma treatment. WOMAC is a 
questionnaire that evaluates knee osteoarthritis. The questions are divided into 3 subscales: pain, 
stiffness, and physical function. Each one of these subscales are numerically rated. The higher 
number signifies more pain, more stiffness, or worst knee function.11,12 One study used an 
unspecified numerical scale to rate OA knee pain. 10 This paper focused on the pain scale while 
walking.  
Kuptniratsaikul et Al. 2009 randomly selected patients into two groups. One group was 
treated by Curcuma and the other by ibuprofen. The patients walked 100m on a leveled surface 
and rated their knee pain numerically. The numerical scale was not specified. The mean scores of 
the outcomes were collected at weeks 0, 2, 4, and 6.10 The physicians were unaware of which 
group of patients they were treating.10 Kuptniratsaikul et al 2014 used WOMAC modified Thai 
version comparing Curcuma to ibuprofen treatment. Patients walked for 6 minutes and then used 
a 0-10 scale to quantify their knee pain. The outcomes were recorded at week 2 and 4. Double 
blinding was achieved in this study.11 Srivastava et al compared Curcuma with a placebo group.  
The outcomes used were WOMAC rating the knee pain from 0-4, as well as assessing the visual 
analog scale (VAS) for knee pain. VAS is a questionnaire with a 10-cm horizontal line with 
word description along with numerical numbers, ranging from 0-10. Zero indicating “no pain” 
and 10 meaning “unbearable”.12 Patients were assessed on days 0, 60, and 120. Double blinding 
was achieved in the study.12 
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RESULTS 
Two studies compared the effectiveness of Curcuma to ibuprofen for reducing OA knee 
pain, and one study compared Curcuma with diclofenac to a placebo with diclofenac on OA knee 
pain. All three studies selected patients for the study based off the knee OA guidelines issued by 
the American College of Rheumatology. These guidelines consist of adults 50 years and older 
with knee pain and stiffness lasting less than 30 minutes, along with crepitus and 
osteophytes.10,11,12  
 Kuptniratsaikul et al 2009 was a single blind randomized control study that was 
conducted in a tertiary hospital in Bangkok, Thailand. A total of 107 patients were selected.  The 
C. domestica extract group had 52 randomized patients and 55 were randomized to ibuprofen 
group. At the end of the trial, 45 patients were left in the Curcuma group and 46 in the ibuprofen 
group. Inconvenience for the follow up return and adverse reactions to either Curcuma or 
ibuprofen caused patients to not complete the study, resulting in 86.5% compliance for Curcuma 
and 83.6% for ibuprofen. One group received 500mg 4 times a day of Curcuma domestica 
extract while the other received 400mg twice a day of ibuprofen for 6 weeks. They had patients 
walk 100 meters on a level surface and then they rated their pain on a numerical scale. They 
calculated the mean score of the rated pain as well as the change score for each group. The 
confidence interval was obtained from the difference of change score for the past 6 weeks in both 
groups.
The p-value of 0.2 was calculated showing that there is no statistical significance in OA knee 
pain for Curcuma compared to ibuprofen even though the numerical pain score showed a 
decrease in pain. The study states their wide range of the confidence interval showed an 
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inadequate sample size. Another possible factor in a large confidence interval could be a large 
age range and geographically limited study participants.  
Table 2: change scale and Confidence interval of Pain on level walking between week 0 to 
610 
 Change score of 
C. Domestica  




(95% CI)  
 
P-Value  
Pain on level 
walking  
2.7 ± 2.6 2.0±2.3  0.67  
(-0.35 to 1.68)  
0.20  
  *Difference= change in score of C. domestica – Change in score of ibuprofen  
Kuptniratsaikul et al 2014 conducted their double blind RCT in tertiary Thailand 
hospitals.185 patients were randomly assigned to C. domestica and 182 to ibuprofen. At the end 
of the trial there were 171 patients left for C. domestica and 160 for ibuprofen, making the 
compliance for C. domestica 92.4% and 88.9% for ibuprofen. One patient from the C. domestica 
withdrew from the adverse effects and 6 withdrew from ibuprofen. The rest were unable to be 
contacted, inconvenienced, or left for other reasons which were not specified. The C. domestica 
group was given 1,500 mg/day for 4 weeks and ibuprofen group were given a dosage of 1,200 
mg/day for 4 weeks. The participants walked for 6 minutes then used the WOMAC pain scale, 
rating the pain from 0 to 10. The p-value of 0.018 shows statistical significance since it is less 
than 0.05.  
Table 4. Mean Standard deviation (SD) and Mean Difference of WOMAC Pain at Week 4 
Adjusted by Week 0 in Ibuprofen and Curcuma domestica Groups11 
Mean score at 
week 4 adjusted 
by week 0 ±SD 
Ibuprofen  
(n=160) 
C. domestica  
(n=171)  






3.17±1.98 3.25±2.11 -0.09 
(-0.43 to 0.29)  
0.018 
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Srivastava et al conducted a 4-month double blinded RCT at the out-patient department 
of orthopedics at King George’s Medical University, India. Inclusion and exclusion criteria can 
be reviewed on table 1. Initially, 78 patients were randomly placed in Curcuma longa group and 
82 in the placebo group. At the end of the 4 months, 66 patients from the Curcuma longa group 
and 67 patients from the placebo group were analyzed, making 84.6% for Curcuma and 81.7% 
for placebo completion. The reason for the low completion is that the patients failed to follow up. 
Both groups received 500mg capsules twice daily. One group received Curcuma longa and the 
other a placebo. Both groups also received 50mg of diclofenac daily. Patients were evaluated at 
day 0, 60 and 120. OA knee pain was evaluated using VAS rating the pain 0 to 10 and WOMAC 
pain scale of 0 to 4. The results were presented as mean with standard error. An unpaired t-test 
was used to compare the variables among VAS and WOMAC scores. A paired t-test was used to 
compare the mean change between days 0 to 120 from the VAS and WOMAC pain scores. A p-
value <0.05 is considered significant. The p-value of both scores showed a statistically 
significant reduction in pain compared to the placebo group.   
Table 6. Mean Change Comparison From Day 0 to 120 in VAS and WOMAC Pain Score12  
 Curcuma Longa 
(n=78)  










VAS score day 0 
to day 120 
3.91 ± 0.14 0.0001 2.54 ± 0.21 0.0001 
WOMAC pain 
score day 0 to 
120 
5.61 ± 0.34  0.0001 5.13 ± 0.33 0.0001  
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DISCUSSION 
Curcuma extracts can be found in many grocery stores or over the counter at a pharmacy. 
However, many insurances are reluctant to cover it since herbal therapy falls under alternative 
medicine. It is important to note that Medicare only covers chiropractors when it comes to 
complementary and alternative medicine13. Herbal coverage is not covered under Medicare.  
Curcumin is not currently widely used in pharmacology for its low systemic 
bioavailability when used orally. Historically, tumeric has been used medically for centuries 
throughout the world. It is widely used in India for wound healing properties and in China for 
abdominal pain. Even though this herb has been around for centuries, there are not many clinical 
trials on it.14 Clinical trials conducted on curcumin show its possible effectiveness are for allergic 
rhinitis, depression, hyperlipidemia, and nonalcoholic fatty liver diease. It is a known anti-
inflammatory. Research shows it decreases inflammatory markers such as cytokines, 
collagenase, elastase, and hyaluronidase.14,15 Curcumin is shown to be well tolerated with few 
side effects. As noted in all 3 studies, the adverse effects are mild. Curcumin should be avoided 
prior to surgery since it can slow blood clotting. It can also interact with anticoagulation and 
antiplatelet medications since it increases bleeding.14 It can also interact with CYP2D6 and 
CYP3A substrates. Patients with gall stones, bile duct, passage obstruction or turmeric 
hypersensitivity should not take curcumin.15  
There are some limitations that were found in the studies. Kuptniratsaikul et al 2009 had 
an inadequate sample size, subtherapeutic dosage of 800mg/daily of ibuprofen given, and it was 
not a double blinded study.10 Additionally, WOMAC and VAS scores are subjective.12 All three 
studies patients were sampled in either India or Thailand, which limits the generalizability. Pain 
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and pain rating scores are also subjective, some patients had unilateral knee pain while others 
were bilateral which can alter the pain score. The third study used rescue medication as an 
edition to both the groups which could alter the pain score as well. The studies did not look into 
what would happen if curcumin and ibuprofen were taken together.  
CONCLUSION 
Studies have shown Curcuma to be effective for knee OA pain with little adverse effects 
and with fewer GI effects than ibuprofen.10, 15 Further research needs to be done since there were 
some conflicting evidences with one of the studies and there are no studies conducted in the 
United States population. Each study also used different amounts and types of Curcuma extracts. 
The three studies show Curcuma is promising as a long-term treatment for knee osteoarthritis 
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